Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima.

Xianglan LiuRuoxi ZhangGuosheng FuYong SunJian WuMaomao ZhangJinwei TianXia GuYang ZhengChengming ShiJingbo HouBo Yu

Published in: Cardiovascular drugs and therapy (2021)

Low-dose MTX may be a key means of promoting early cell coverage via the inhibition of the inflammatory response and stability of neointima by targeting inflammatory pathways after stent implantation.

Keyphrases

low dose
inflammatory response
single cell
cell therapy
high dose
smooth muscle
oxidative stress
affordable care act
healthcare
toll like receptor
angiotensin ii